LSU’s Pennington Biomedical Research Center is looking for volunteers for a first-of-its-kind study to slow memory loss as a result of Alzheimer’s.
Director of Pennington’s Institute for Dementia Research, Dr. Jeffery Keller, says they’re seeking people ages 50 to 85 who are concerned about their memory and don’t have a confirmed case of Alzheimer’s Disease to undergo this new investigational treatment.
“It’s extremely promising because this approach has appeared to be something that moves to the needle in people with Alzheimer’s Disease and to see if this drug can actually prevent Alzheimer’s Disease from occurring.”
Keller says this is a lengthy three year study, but it’s necessary because the disease forms in individuals who are asymptomatic and don’t show symptoms. He says Alzheimer’s is the sixth leading cause of death in the country, with 15 million people expected to be diagnosed by 2050.
“Even if we find a treatment for Alzheimer’s, it’s going to be difficult to sustain our society and our healthcare system with 15 million people having Alzheimer’s Disease.”
Keller says this study is extremely promising because this approach has appeared to be something that’s moved the needle in people with Alzheimer’s. He says they hope this drug can prevent people without symptoms from developing the disease later in life.
“There has been a phase 2 Alzheimer’s study where this was study to have beneficial effect in patients with Alzheimer’s disease.”
For more information about the study visit www.pbrc.edu/A4 or call (225) 763-2972